Preface
Preface
Translational Lung Cancer Research
2017;
6
(6)
:613-614
.
(16 October 2017)
Editorial
Research in imaging/biomarkers for precision medicine in lung cancer: National Cancer Institute funding opportunities
Translational Lung Cancer Research
2017;
6
(6)
:615-616
.
(16 October 2017)
Perspective
Role of PET/CT for precision medicine in lung cancer: perspective of the Society of Nuclear Medicine and Molecular Imaging
Translational Lung Cancer Research
2017;
6
(6)
:617-620
.
(16 October 2017)
Brief Report
The role of Imaging and Radiation Oncology Core for precision medicine era of clinical trial
Translational Lung Cancer Research
2017;
6
(6)
:621-624
.
(16 October 2017)
Original Article
Ensuring sample quality for blood biomarker studies in clinical trials: a multicenter international study for plasma and serum sample preparation
Translational Lung Cancer Research
2017;
6
(6)
:625-634
.
(16 October 2017)
Review Article
Radiomics in precision medicine for lung cancer
Translational Lung Cancer Research
2017;
6
(6)
:635-647
.
(16 October 2017)
Blood-based tumor biomarkers in lung cancer for detection and treatment
Translational Lung Cancer Research
2017;
6
(6)
:648-660
.
(16 October 2017)
Blood-based biomarkers for precision medicine in lung cancer: precision radiation therapy
Translational Lung Cancer Research
2017;
6
(6)
:661-669
.
(16 October 2017)
Anatomic, functional and molecular imaging in lung cancer precision radiation therapy: treatment response assessment and radiation therapy personalization
Translational Lung Cancer Research
2017;
6
(6)
:670-688
.
(16 October 2017)
Magnetic resonance imaging in precision radiation therapy for lung cancer
Translational Lung Cancer Research
2017;
6
(6)
:689-707
.
(16 October 2017)
Mini-Review
Blood-based biomarkers in lung cancer: prognosis and treatment decisions
Translational Lung Cancer Research
2017;
6
(6)
:708-712
.
(16 October 2017)
Editorial
Potential future consideration for imaging and blood-based biomarkers for precision medicine in lung cancer
Translational Lung Cancer Research
2017;
6
(6)
:713-715
.
(16 October 2017)
Disclosure:
The focused issue “Imaging- and blood-based biomarkers for lung cancer precision medicine” was commissioned by the editorial office, Translational Lung Cancer Research without any sponsorship or funding. Feng-Ming (Spring) Kong served as the unpaid Guest Editor for the focused issue.
